초록 ▼

A method for bonding a polymeric medical device to tissue is provided which includes providing a polymeric medical device having a plurality of reactive members of a specific binding pair attached on a surface of the medical device, and providing tissue with a plurality of complementary reactive mem

A method for bonding a polymeric medical device to tissue is provided which includes providing a polymeric medical device having a plurality of reactive members of a specific binding pair attached on a surface of the medical device, and providing tissue with a plurality of complementary reactive members of the specific binding pair, wherein upon contact of the reactive members on the surface of the medical device with the complimentary reactive members on the tissue, covalent bonds are formed between the reactive members and the complementary reactive members, thus adhering the device to the tissue. A kit is provided including a polymeric medical device such as a patch or mesh having a plurality of reactive members of a specific binding pair attached to a surface of the device and an applicator containing a solution or suspension of complementary reactive members of the specific binding pair, the complementary reactive members having a functionality that will adhere them to biological tissue upon contact, said applicator adapted to deliver the solution or suspension to biological tissue.

대표청구항 ▼

1. A method for bonding a polymeric medical device to biological tissue comprising: providing a polymeric medical device having a plurality of reactive members attached on a surface of the medical device;providing tissue having a plurality of complementary reactive members; andcontacting the medical

1. A method for bonding a polymeric medical device to biological tissue comprising: providing a polymeric medical device having a plurality of reactive members attached on a surface of the medical device;providing tissue having a plurality of complementary reactive members; andcontacting the medical device with the tissue, wherein upon contact of the reactive members on the surface of the medical device with the complimentary reactive members on the tissue, covalent bonds are formed between the reactive members and the complementary reactive members, thus adhering the medical device to the tissue, and wherein the reactive members and the complementary reactive members are selected from alkynes and azides. 2. The method for bonding a polymeric medical device to biological tissue according to claim 1 wherein the reactive members and the complementary reactive members bind to one another via a Huisgen cycloaddition reaction. 3. The method for bonding a polymeric medical device to biological tissue according to claim 1 wherein the reactive member is an alkyne and the complementary reactive member is an azide. 4. The method for bonding a polymeric medical device to biological tissue according to claim 1 wherein the reactive members is an azide and the complementary reactive member is an alkyne. 5. The method for bonding a polymeric medical device to biological tissue according to claim 2 wherein the reaction is catalyzed by copper to activate an alkyne and an azide for [3+2] cycloaddition. 6. The method for bonding a polymeric medical device to biological tissue according to claim 2 wherein the reaction involves a cyclooctyne reagent and an azide for [3+2] cycloaddition. 7. The method for bonding a polymeric medical device to biological tissue according to claim 2 wherein the tissue is provided with complementary reactive members by applying a mixture or an aerosol containing the complementary reactive members to the tissue, the complementary reactive members being conjugated to a linker adapted to link the complementary reactive members to the tissue. 8. The method for bonding a polymeric medical device to biological tissue according to claim 7 wherein the complementary reactive members are attached to the tissue via an RGD linker. 9. The method for bonding a polymeric medical device to biological tissue according to claim 7 wherein the complementary reactive members are attached to the tissue via a ligand-receptor linkage. 10. The method for bonding a polymeric medical device to biological tissue according to claim 9 wherein the complementary reactive members are conjugated to a linker selected from the group consisting of antibody, Fab, F(ab′)2, Fv, single chain antibody (SCA) and single complementary-determining region (CDR). 11. The method for bonding a polymeric medical device to biological tissue according to claim 7 wherein the linker is degraded by hydrolysis or enzymatic action. 12. The method for bonding a polymeric medical device to biological tissue according to claim 7 wherein the ligand binds to a receptor selected from the group consisting of peptides, oligosaccharides, oligonucleotides and lipids. 13. The method for bonding a polymeric medical device to biological tissue according to claim 2 wherein the medical device is provided with the reactive members by surface modification techniques selected from the group consisting of plasma treatment, silane coupling treatment and acid sensitization. 14. The method for bonding a polymeric medical device to biological tissue according to claim 1 wherein the medical device is a mesh or a patch. 15. The method for bonding a polymeric medical device to biological tissue according to claim 14 wherein the patch is made of foam, woven material and non-woven material. 16. The method for bonding a polymeric medical device to biological tissue according to claim 1 wherein the medical device is made of a polymer selected from the group consisting of polycarbonates, polyolefins, polymethacrylates, polystyrenes, polyamides, polyurethanes, polyethylene terephthalate, poly (lactic acid), poly (glycolic acid), poly (hydroxbutyrate), dioxanones (e.g., 1,4-dioxanone), .delta.-valerolactone, 1,dioxepanones (e.g., 1,4-dioxepan-2-one and 1,5-dioxepan-2-one), poly (phosphazine), polyesters, polyethylene glycol, polyethylene oxides, polyacrylamides, cellulose esters, fluoropolymers, vinyl polymers, silk, collagen, alginate, chitin, chitosan, hyaluronic acid, chondroitin sufate, polyhydroxyethylmethylacrylate, polyvinylpyrrolidone, polyvinyl alcohol, polyacrylic acid, polyacetate, polycaprolactone, polypropylene, glycerols, poly(amino acids), copoly (ether-esters), polyalkylene oxalates, polyamides, poly (iminocarbonates), polyalkylene oxalates, polyoxaesters, polyorthoesters, polyphosphazenes, polypeptides and copolymers, block copolymers, homoploymers, blends and combinations thereof.